AdooQ BioScience is a supplier of biochemicals located in Irvine, CA since 2006. In the past five years, we have been a renowned name engaged in manufacturing and supplying small molecule inhibitors including kinase inhibitors on kinds of signal pathway, such as PI3K, AKT, HDAC, MARP etc.
Company WebsiteRifamdin is a Rifamicyn derivative with therapeutic effect on pulmonary tuberculosis.
More Information Supplier PageRifamdin is a Rifamicyn derivative with therapeutic effect on pulmonary tuberculosis.
More Information Supplier PageRifamdin is a Rifamicyn derivative with therapeutic effect on pulmonary tuberculosis.
More Information Supplier PageAntibiotic; inhibits bacterial RNA polymerase. Prototypical activator of the pregnane X receptor (PXR).
More Information Supplier PageAntibiotic; inhibits bacterial RNA polymerase. Prototypical activator of the pregnane X receptor (PXR).
More Information Supplier PageAntibiotic; inhibits bacterial RNA polymerase. Prototypical activator of the pregnane X receptor (PXR).
More Information Supplier PageAntibiotic; inhibits bacterial RNA polymerase. Prototypical activator of the pregnane X receptor (PXR).
More Information Supplier PageAntibiotic; inhibits bacterial RNA polymerase. Prototypical activator of the pregnane X receptor (PXR).
More Information Supplier PageRifapentine is an antibiotic drug used in the treatment of tuberculosis.
More Information Supplier PageRifapentine is an antibiotic drug used in the treatment of tuberculosis.
More Information Supplier PageRifapentine is an antibiotic drug used in the treatment of tuberculosis.
More Information Supplier PageRifapentine is an antibiotic drug used in the treatment of tuberculosis.
More Information Supplier PageRifaximin is a semisynthetic, rifamycin-based non-systemic antibiotic, meaning that very little of the drug will pass the gastrointestinal wall into the circulation as is common for other types of orally administered antibiotics.
More Information Supplier PageRifaximin is a semisynthetic, rifamycin-based non-systemic antibiotic, meaning that very little of the drug will pass the gastrointestinal wall into the circulation as is common for other types of orally administered antibiotics.
More Information Supplier PageRifaximin is a semisynthetic, rifamycin-based non-systemic antibiotic, meaning that very little of the drug will pass the gastrointestinal wall into the circulation as is common for other types of orally administered antibiotics.
More Information Supplier PageRifaximin is a semisynthetic, rifamycin-based non-systemic antibiotic, meaning that very little of the drug will pass the gastrointestinal wall into the circulation as is common for other types of orally administered antibiotics.
More Information Supplier PageRifaximin is a semisynthetic, rifamycin-based non-systemic antibiotic, meaning that very little of the drug will pass the gastrointestinal wall into the circulation as is common for other types of orally administered antibiotics.
More Information Supplier PageRilmenidine is a second-generation imidazoline-??2 adrenergic agonist.
More Information Supplier PageRilmenidine is a second-generation imidazoline-??2 adrenergic agonist.
More Information Supplier PageRilmenidine is a second-generation imidazoline-??2 adrenergic agonist.
More Information Supplier PageRilmenidine is a second-generation imidazoline-??2 adrenergic agonist.
More Information Supplier PageRilmenidine Phosphate is a selective I(1) imidazoline receptor agonist.
More Information Supplier PageRilmenidine Phosphate is a selective I(1) imidazoline receptor agonist.
More Information Supplier PageRilmenidine Phosphate is a selective I(1) imidazoline receptor agonist.
More Information Supplier PageRilpivirine is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with higher potency, longer half-life and reduced side-effect profile compared with older NNRTIs, such as efavirenz.
More Information Supplier PageRilpivirine is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with higher potency, longer half-life and reduced side-effect profile compared with older NNRTIs, such as efavirenz.
More Information Supplier PageRilpivirine is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with higher potency, longer half-life and reduced side-effect profile compared with older NNRTIs, such as efavirenz.
More Information Supplier PageRilpivirine is a second-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) with higher potency, longer half-life and reduced side-effect profile compared with older NNRTIs, such as efavirenz.
More Information Supplier PageRiluzole preferentially blocks TTX-sensitive sodium channels, which are associated with damaged neurons.This reduces influx of calcium ions and indirectly prevents stimulation of glutamate receptors.
More Information Supplier PageRiluzole preferentially blocks TTX-sensitive sodium channels, which are associated with damaged neurons.This reduces influx of calcium ions and indirectly prevents stimulation of glutamate receptors.
More Information Supplier PageRiluzole preferentially blocks TTX-sensitive sodium channels, which are associated with damaged neurons.This reduces influx of calcium ions and indirectly prevents stimulation of glutamate receptors.
More Information Supplier PageRiluzole preferentially blocks TTX-sensitive sodium channels, which are associated with damaged neurons.This reduces influx of calcium ions and indirectly prevents stimulation of glutamate receptors.
More Information Supplier PageRimantadine is an orally administered antiviral drug used to treat, and in rare cases prevent, influenzavirus A infection. Rimantadine is believed to inhibit influenza’s viral replication, possibly by preventing the uncoating of the virus’s protective shells, which are the envelope and capsid.
More Information Supplier PageRimantadine is an orally administered antiviral drug used to treat, and in rare cases prevent, influenzavirus A infection. Rimantadine is believed to inhibit influenza’s viral replication, possibly by preventing the uncoating of the virus’s protective shells, which are the envelope and capsid.
More Information Supplier PageRimantadine is an orally administered antiviral drug used to treat, and in rare cases prevent, influenzavirus A infection. Rimantadine is believed to inhibit influenza’s viral replication, possibly by preventing the uncoating of the virus’s protective shells, which are the envelope and capsid.
More Information Supplier PageRimonabant is a selective antagonist of CB1 with IC50 of 13.6 nM and EC50 of 17.3 nM in hCB1 transfected HEK 293 membrane.
More Information Supplier PageRimonabant is a selective antagonist of CB1 with IC50 of 13.6 nM and EC50 of 17.3 nM in hCB1 transfected HEK 293 membrane.
More Information Supplier PageRimonabant is a selective antagonist of CB1 with IC50 of 13.6 nM and EC50 of 17.3 nM in hCB1 transfected HEK 293 membrane.
More Information Supplier PageRimonabant is a selective antagonist of CB1 with IC50 of 13.6 nM and EC50 of 17.3 nM in hCB1 transfected HEK 293 membrane.
More Information Supplier PageRimonabant is a selective antagonist of CB1 with IC50 of 13.6 nM and EC50 of 17.3 nM in hCB1 transfected HEK 293 membrane.
More Information Supplier PageRiociguat (BAY 63-2521; BAY 632521) is a stimulator of soluble guanylate cyclase (sGC).
More Information Supplier PageRiociguat (BAY 63-2521; BAY 632521) is a stimulator of soluble guanylate cyclase (sGC).
More Information Supplier PageRiociguat (BAY 63-2521; BAY 632521) is a stimulator of soluble guanylate cyclase (sGC).
More Information Supplier PageRiociguat (BAY 63-2521; BAY 632521) is a stimulator of soluble guanylate cyclase (sGC).
More Information Supplier PageRisedronate sodium is a bisphosphonate used to strengthen bone, treat or prevent osteoporosis, and treat Paget’s disease of bone.
More Information Supplier PageRisedronate sodium is a bisphosphonate used to strengthen bone, treat or prevent osteoporosis, and treat Paget’s disease of bone.
More Information Supplier PageRisedronate sodium is a bisphosphonate used to strengthen bone, treat or prevent osteoporosis, and treat Paget’s disease of bone.
More Information Supplier PageRisedronate sodium is a bisphosphonate used to strengthen bone, treat or prevent osteoporosis, and treat Paget’s disease of bone.
More Information Supplier PageRisedronic acid is a bisphosphonate used to strengthen bone, treat or prevent osteoporosis, and treat Paget’s disease of bone.
More Information Supplier PageRisperidone(Risperdal) is an atypical antipsychotic used to treat schizophrenia (including adolescent schizophrenia), schizoaffective disorder, the mixed and manic states associated with bipolar disorder, and irritability in children with autism.
More Information Supplier Page
